April 17, 2007 — Canadian researchers have learned that about one quarter of heart failure patients have moderate-to-severe obstructive sleep apnea and they also have significantly higher death rates than those without sleep apnea.

Dr. Hanqiao Wang and colleagues at the University of Toronto in Ontario conducted a study of 164 patients who were referred to the Heart Failure Clinic of Mt. Sinai Hospital between 1997 and December 2004. Standard sleep tests were performed to diagnose sleep apnea.

April 17, 2007 — ZOLL Medical Corp. announced the top winners of the ZOLL CPR Challenge that took place in the company's booth during the recent EMS Today Conference and Expo 2007 in Baltimore, including two youths who out-performed many professionals in the hour in which they competed. Two-hundred and forty-five (245) attendees performed more than 40,000 chest compressions over the course of the conference.

April 16, 2007 — Boston Scientific Corp. has announced it has resolved the deficiencies in the warning letter issued by the U.S. Food and Drug Administration (FDA) to the Guidant Corp. on Dec. 22, 2005, and that all associated restrictions have been removed. Boston Scientific acquired Guidant last year.

April 16, 2007 - Endologix, Inc. has announced the first three successful implantations of the Powerlink endoluminal stent graft (ELG) incorporating the Visiflex SurePass Delivery System.

The Visiflex SurePass is the company's next-generation delivery device that allows physicians continued guide wire access to the contralateral limb of the unibody Powerlink ELG device.

April 16, 2007 — LegalView.com has added a database of up-to-date information about FDA-approved drugs, which includes practice areas on unsafe drugs, recall information for medications such as Zelnorm, Procrit and Pergolide, and informative articles and blogs on medical devices like the Composix hernia mesh patch and Guidant defibrillators.